×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Astrocytic Pathology in Progressive Supranuclear Palsy
mechanism
2,308 words
KG: ent-dise-bfd8f32d
2026-04-01
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
Astrocytic Pathology in Progressive Supranuclear Palsy
⚙
Mechanism Info
Name
Astrocytic Pathology in Progressive Supranuclear Palsy
Summary
Page for Astrocytic Pathology in Progressive Supranuclear Palsy
Knowledge Graph
Related Hypotheses (11)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli
Score: 0.46
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
Score: 0.41
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.45
Show 6 more
Related Analyses (30)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Show 25 more
Related Experiments (22)
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40
Environmental Exposure Causal Attribution in ALS — Experimen
validation · proposed · Score: 0.40
FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio
validation · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Pre-Symptomatic Detection and Intervention Timing in Genetic
validation · proposed · Score: 0.40
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40
Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Sleep and Respiratory Network Interaction in ALS — Experimen
clinical · proposed · Score: 0.40
TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40
Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40
Show 17 more
See Also (15)
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 3 hypotheses
sglt2-inhibitors-neurodegeneration
therapeutic · Pages share 3 hypotheses
RIPK1 Inhibitors for Neurodegeneration
therapeutic · Pages share 3 hypotheses
Nanoparticle Drug Delivery for Neurodegeneration
therapeutic · Pages share 3 hypotheses
TYROBP/DAP12 Microglia Signaling Pathway in Alzheimer's
mechanism · Pages share 3 hypotheses
Thyroid Hormone Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Synaptic Spine Degradation Pathway in Alzheimer's Disea
mechanism · Pages share 3 hypotheses
Synaptic Loss in Alzheimer's Disease Pathway
mechanism · Pages share 3 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 3 hypotheses
RNA-Targeted Therapies in Neurodegeneration
mechanism · Pages share 3 hypotheses
RAGE (Receptor for Advanced Glycation End Products) Sig
mechanism · Pages share 3 hypotheses
PSP Astrocytic Pathology: Tufted Astrocytes Mechanism
mechanism · Pages share 3 hypotheses
Prionoid Propagation of Protein Aggregates in Neurodege
mechanism · Pages share 3 hypotheses
PPAR Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Neurovascular Unit Dysfunction in Neurodegeneration
mechanism · Pages share 3 hypotheses
Show 10 more